Medical Advancements

Small cell lung cancer (SCLC) stands as a formidable and aggressive subtype of lung cancer, notorious for its rapid growth and propensity to metastasize early. Accounting for nearly 15% of all lung cancer cases, SCLC is characterized by its quick progression, often spreading to distant organs by the time of diagnosis. This cancer type’s aggressive nature necessitates ongoing research endeavors to unlock novel treatment modalities and enhance survival rates in patients with the disease. ASTRIDE is a Phase 3 clinical trial for the treatment of SCLC.

Make better decisions in the moment with the most accurate CGM. The Dexcom G7 delivers the most accurate real-time blood glucose numbers directly to your smartphone or smartwatch. So you can see your glucose levels and where they’re headed, make smarter decisions about food and activity in the moment, and take better control of your diabetes.